These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [General facts on mastocytoma in the dog. Apropos of the first Tunisian case]. Zarrouk K, Chadli A, Fontaine M, Ben Zina F. Arch Inst Pasteur Tunis; 1979 Sep; 56(3):255-78. PubMed ID: 122139 [Abstract] [Full Text] [Related]
24. Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998). Hahn KA, King GK, Carreras JK. J Am Vet Med Assoc; 2004 Jan 01; 224(1):79-82. PubMed ID: 14710881 [Abstract] [Full Text] [Related]
27. Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival. Krick EL, Billings AP, Shofer FS, Watanabe S, Sorenmo KU. Vet Comp Oncol; 2009 Jun 01; 7(2):130-8. PubMed ID: 19453367 [Abstract] [Full Text] [Related]
28. What is your diagnosis? Mast cell sarcoma. Dunn K. J Small Anim Pract; 1997 Mar 01; 38(3):93, 108. PubMed ID: 9097238 [No Abstract] [Full Text] [Related]
29. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. Weisse C, Shofer FS, Sorenmo K. J Am Anim Hosp Assoc; 2002 Mar 01; 38(1):71-3. PubMed ID: 11804319 [Abstract] [Full Text] [Related]
30. Tumors of the skin and associated structures. Meleo KA. Vet Clin North Am Small Anim Pract; 1997 Jan 01; 27(1):73-94. PubMed ID: 9002168 [Abstract] [Full Text] [Related]
32. Tolerance of cutaneous or mucosal flaps placed into a radiation therapy field in dogs. Séguin B, McDonald DE, Kent MS, Walsh PJ, Théon AP. Vet Surg; 2005 Jan 01; 34(3):214-22. PubMed ID: 16115077 [Abstract] [Full Text] [Related]
33. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Patnaik AK, Ehler WJ, MacEwen EG. Vet Pathol; 1984 Sep 01; 21(5):469-74. PubMed ID: 6435301 [Abstract] [Full Text] [Related]
35. Prognosis for treatment of tumors. Curtis CR, Straw RC. J Am Vet Med Assoc; 1989 Feb 01; 194(3):324-5. PubMed ID: 2492982 [No Abstract] [Full Text] [Related]
36. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001). Gieger TL, Théon AP, Werner JA, McEntee MC, Rassnick KM, DeCock HE. J Vet Intern Med; 2003 Feb 01; 17(5):687-92. PubMed ID: 14529136 [Abstract] [Full Text] [Related]
37. Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors. Hahn KA, Legendre AM, Shaw NG, Phillips B, Ogilvie GK, Prescott DM, Atwater SW, Carreras JK, Lana SE, Ladue T, Rusk A, Kinet JP, Dubreuil P, Moussy A, Hermine O. Am J Vet Res; 2010 Nov 01; 71(11):1354-61. PubMed ID: 21034327 [Abstract] [Full Text] [Related]
38. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases. Michels GM, Knapp DW, DeNicola DB, Glickman N, Bonney P. J Am Anim Hosp Assoc; 2002 Nov 01; 38(5):458-66. PubMed ID: 12220031 [Abstract] [Full Text] [Related]
39. Megavoltage irradiation of neoplasms of the nasal and paranasal cavities in 77 dogs. Théon AP, Madewell BR, Harb MF, Dungworth DL. J Am Vet Med Assoc; 1993 May 01; 202(9):1469-75. PubMed ID: 8496103 [Abstract] [Full Text] [Related]
40. [Electron microscopy demonstration of sulphurated acid mucopolysaccharides in canine mast cell tumors, using barium chloride and ruthenium red, together with comments on the classification and differentiation of tumor cells]. Rudolph R. Arch Exp Veterinarmed; 1971 May 01; 25(6):925-35. PubMed ID: 4113751 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]